March 2021 in “Journal of Maxillofacial and Oral Surgery” This case series reports that beard hair can be used effectively as an adjunct donor site for hair transplantation in severe androgenic alopecia, with minimal complications observed.
This study found that 49% of female breast cancer patients treated with CDK4/6 inhibitors for at least three months developed alopecia, which significantly impacted their quality of life, with greater alopecia severity leading to worse emotional and functional well-being.
This study found that individuals with both androgenetic alopecia and metabolic syndrome had thicker subcutaneous adipose tissue in the frontal scalp, along with unfavorable metabolic parameters, compared to those without metabolic syndrome.
September 2023 in “Medicina Estética Revista Científica de la Sociedad Española de Medicina Estética (SEME)” This research reported that the FDA approved Litfulo® (ritlecitinib) as the first oral treatment for severe alopecia areata in adolescents over 12 years old, with 23% of treated patients showing significant hair regrowth in clinical trials compared to 1.6% with placebo.
9 citations
,
September 2010 in “Dermatologic Therapy” This article concludes that finasteride is a safe treatment for androgenetic alopecia and does not increase the risk of high-grade prostate cancer, despite past concerns from the Prostate Cancer Prevention Trial.